← Table of contents
Immunity in infective diseases

INDEX.

Francis G. Binnie translation

Abrin, 344, 345, 346, 401

Abrin intoxication, action of body fluids on, 365, 420; leucocytic reaction against, 393, 401

Absorption. See Resorption

Acari, mechanical action of, 3

Acclimatisation. See Adaptation

Acid reaction inside phagocytes, 83, 182

Acid, secretion of, in osmosis, 37, 566

Acidophile microbian flora of stomach, 418

Actinians, digestion in, 53, 82, 85

Actinodiastase, 57, 197

Actinophrys, 14, 18

Adaptation. See also Immunity

Adaptation to toxic substances, 21–27, 30, 342, 390; to saline solutions, 23, 30, 515; to physical conditions, 26, 30–31; of plasmodia to arsenious acid, 31; of pancreatic secretion to kind of food, 64, 65; of phagocytes to destroy micro-organisms, 281, 558, 566; of animals to spinal concussion, etc., 564; of cells, 513

Addiment (syn. Complement), 95

Agglutination in natural immunity, 202, 206; and phagocytosis, 202, 242, 245; in the diagnosis of typhoid, 256, 257, 261, 439; its mechanism, 257; of red blood corpuscles by serums, 258; of red blood corpuscles by ricin, 360; does not prevent growth of micro-organisms, 262

Agglutinative power, transmission by heredity or suckling, 450; not developed parallel with bactericidal power, 483

Agglutinins in immunity, 242, 245, 256–265, 295, 542, 559; characters of, 255, 559; origin of, in immunised animal, 263–265, 294; difference between fixatives and, 255, 265, 559; not the same as protective substances, 268, 269, 294

Albuminoid substances, resorption of, 106–127

Alexins. See also Cytases

Alexins, 87–95, 96, 98, 184, 193, 255, 528, 533, 535, 539

Alimentary canal. See Intestine

Alizarin sulpho-acid, 13, 83, 183

Alligator, 77, 143, 332, 401

Amboceptors (syn. fixatives), 91, 93, 297, 557

Ammocoetes, 77, 78

Amoeba, 14, 18, 23, 547, 549

Amoebo-diastase, 16, 197, 549

Amoeboid cells. See Leucocytes and Phagocytes

Amphibia. See Frog, Axolotl

Amylase, 95; in the urine, 65

Androctonus. See Scorpion

Anopheles and malaria, 129

Antagonism between certain bacteria, 323

Anthrax, 11, 20, 21, 25, 41, 46, 180; immunity of dog against, 149–151, 242; acquired immunity of Scolopendra against, 209; natural immunity of white rat against, 526; protective serums against, 20, 276, 309–311; phagolysis in acquired immunity against, 280; immunisation against, by means of other bacteria, 323; infection by inhalation, 412; by ingestion, 423; immunity against, transmitted to offspring, 445, 447; vaccinations against, 208, 241, 468–471; method, 470; statistics, 471; vaccination against, by heated anthrax blood, 507; vaccines against, 208, 470, 509; phagocytosis in, 521, 523

Anthrax bacillus, action on rabies, 150; bactericidal action of blood serums on, 20, 146, 150, 151, 156, 157, 240; increasing the virulence of, 150; attenuation of, 208, 288; eosinophile transformation in, 198; protective thickening of bacterial membrane in, 242; agglutination of, 203, 242, 260, 264; natural immunity against, 132–140, 143, 147, 149–159, 511, 512; acquired immunity against, 239–242, 276, 277; antagonism between, and certain bacteria, 323; fate of, in Algerian sheep, 512; destruction of, by defibrinated blood, 525

Anthrax, symptomatic: immunity against bacilli of, 171; heredity of immunity against, 452; vaccinations against, 471–473; phagocytosis in, 523

Antiabrin, 401

578Anti-arsenic serum, 390

Anticytases, 112

Anticytase serum, 115, 371

Anticytotoxins, 110, 118, 122, 127, 360

Antidiastase, 109

Antidiastatic serums, 361

Anti-enzymes, 109

Antifixative, 112

Antihaemolysins, 111

Antihaemotoxins, 111, 119, 122

Anti-infective. See Protective

Antileucocidin, 359

Antineurotoxin, 116

Antirennet, 109

Antiricin, 360

Antisepsis, Nature replaces by asepsis, 432

Antiseptics. See also Toxins and Adaptation

Antiseptics and foods, 26

Antiseptic action of the gastric juice, 417

Antispermofixative, 124

Antispermotoxins, 116, 122–126

Antistreptococcic serum, 243–245

Antitetanin, nervous origin of, 390

Antitoxic. See also Protective

Antitoxic unit of Ehrlich, 373, 496; action of non-specific and normal serums and of broth, 365; function of the saliva, 417; function of pepsin and other digestive ferments, 419, 424; action of intestinal flora, 427; property of the body fluids, 531 (see Body fluids, Serums); power of the blood of new-born children, 445

Antitoxins, natural, in normal blood, 111, 204, 444; rarity in body fluids in natural immunity, 204, 532, 533; development of, during immunisation, 354; properties of, 354; present in various fluids of immunised animal, 355, 531; mode of action of, on toxins, 356–362, 371; conditions acting in mixtures of, with toxins, 362; immunity against toxins not in direct constant ratio to amount of, 367–376; effect of using serum from same species, 379; hypothesis as to nature and origin of, 377–402, 562; probable part played by phagocytes in production of, 400–402; rapid regeneration of, after bleeding, 379; augmentation in production of, by pilocarpin, 380; transmission of, by milk to offspring, 449; analogy of, with fixatives, 561; hypersecretion of, 563

Antivenomous property of blood of scorpion, 328; action of serums, 334, 338; serum, action of, 334, 338, 358, 360

Aqueous humour, bactericidal action of, 184, 192; in immunised animals contains no fixative, 217, 222; in immunised animals contains antitoxin, 355

Arsenic; adaptation to, 31, 343, 390; protective serum against, 390; leucocytic reaction against, 396–399; as a remedy against microbial disease, 513

Arsenic acid, action of, on anthrax bacillus, 25

Arsenious acid, adaptation of plasmodia to, 31

Arthropoda. See Clothes-moth, Crayfish, Crustacea, Daphnia, Scolopendra, Scorpion, Spider, Tick

Arthrospores of Hueppe, 254

Ascaris, poor microbian flora in intestine of, 421; phagocytic organs of, 547

Asepsis is Nature’s method, 432

Aspergillosis, 2, 4. See also Mycoses

Atrophic diseases, probably due to a parasite, 3

Atropin, reaction of rabbit and guinea-pig to, 395, 396

Attenuation. See also Vaccination, Vaccines

Attenuation of micro-organisms and viruses, discovery and application of, 208, 247, 288, 508; of micro-organisms by the fluids of immunised animals, 286–289; of toxins, 344

Autodigestion in yeast, 197

Autospermotoxins, 101

Autotoxins, 104

Axolotl, susceptible to tetanus toxin, 330

Bacilli, anaerobic, natural immunity against, 169, 170

Bacillus aërogenes, agglutination in, 264

Bacillus chauraei. See Anthrax symptomatic

Bacillus coli attacks potato, 35; vaccination against, 267; transformation of, into granules, 198; modified growth on certain serums, 259

Bacillus of Doederlein, 429; of Kiel water, 408

Bacillus pyocyaneus, 42, 180, 254, 528; acquired immunity against, 210, 232–236, 301; Pfeiffer’s phenomenon in, 234, 307; special forms of growth in serums from vaccinated animals, 256; agglutination of, 261, 307; susceptibility to the toxins of, 290, 351; action of specific serum on, 307, 358; antagonistic to anthrax bacillus, 323; immunisation against toxin of, 351; a leucocidin from, 359; action of liver on toxin of, 427; heredity of immunity against toxin of, 446

Bacillus ranicida, 140

Bacteria. See Micro-organisms

Bactericidal action of serum, influence of alkalinity or acidity on, 196; function of the tears, 408

Bactericidal property. See also Body fluids, Humoral theory, Serums

Bactericidal property: in blood and other fluids, 20, 146, 150, 151, 156, 157, 184–193, 211, 226, 233, 238, 240, 241, 243, 244, 512, 525–531, 542, 554; of body fluids, theory of osmotic pressure, 193, 213; 579of extracts of glands and exudations, 195; of the saliva, 415; absence of, from the intestinal ferments, 424, 567; of serums, Wright’s method of testing, 483; does not develop parallel with agglutinative, 483; and immunity, absence of parallelism, 554

Bactericidal substance (alexin, complement, cytase): in blood and other fluids, 184–193, 534; source of, in body fluids, 185–193; theory of leucocytic secretions, 187–191; presence in body fluids due to phagolysis, 191; is of phagocytic origin, 185, 192; in body fluids, microphages source of, 187; not resistant to heat, 268; and so distinguished from protective substance, 268; Pfeiffer’s theory of, 534

Bacteriolysis. See Micro-organisms, destruction of

Bacteriolysis, analogy between haemolysis and, 537

Bat, immunity against tetanus of hibernating, 339

Baumès-Colles’ law in syphilis, 436

Behring’s “normal serum,” 496

Bile, function of, 60; salts protective against snake venom, 388; protective function of, 424

Bipinnaria, 70, 518

Blastomycetes. See also Yeast-cells

Blastomycetes, resistance of Daphnia to, 131, 404, 520; fate of, in refractory organism, 172; acidophile, 418

Blood, pepsin in the, 66, 563; precipitins in the, 68, 106, 107, 568; fate of effusions of, 73; bactericidal power of, 184 (see also Bactericidal, Serums); natural antitoxins in normal, 111, 204, 444; stimulant (protective) action of human, 271, 318; immunity conferred by maternal, 447; recognition of, in medico-legal research, 107, 568; from convalescents, protective power of, 437, 441, 443; agglutination of (see Agglutination)

Blood corpuscles, resorption of red, 47, 50, 56, 57, 70, 72, 79–100, 537 (see also Haemolysis); fixation of cytase by red, 194; agglutination of red, by serums, 258; agglutination of red, by ricin, 360

Body fluids. See also Bactericidal, Blood, Humoral theory, Serums

Body fluids, natural immunity and the composition of, 128–131, 146; in natural immunity, absence of antitoxic property in, 204; bactericidal power of, 184–193, 512, 525–531, 542 (see also Body fluids, Serums); antitoxic power of the, 204, 531, 533, 543; protective properties of, 266–280

Boophilus bovis, 247

Bordet’s sensibilising substance, 91, 199, 298, 535, 537, 557

Botulism, protective action of fats against toxin of, 387; action of digestive diastases on toxin of, 420

Bouchard’s theory of acquired immunity, 232, 286; of attenuating power of serums, 286–289

Bouillon de panse, 473

Bovidae, acquired immunity of, against Texas fever, 247, 279; protection of, against tetanus, 494; vaccination of, against rinderpest, 425, 466–468; against rabies, 466; against anthrax, 470; against symptomatic anthrax, 471; against pleuropneumonia, 477–479; ancient methods against pleuropneumonia in, 506

Broth as a protective fluid, 320, 321, 365

Buccal cavity, microbial products in the protection of the, 416; flora of, 414

Buchner’s theory of immunity, 512, 527

Calf lymph vaccine, method of preparation, 456

Carassius. See Goldfish

Carmine, fixation of tetanus toxin by, 388, 394

Cattle. See Bovidae

Cattle plague. See Rinderpest

Cayman. See Alligator

Cellular or histogenic immunity, 335, 336, 340, 563–565

Cellulosase, 86

Cerebral substance, action of emulsions of, on toxins, 386

Cerebral tetanus, 383, 391

Chemiotaxis. See also Hyperleucocytosis, Susceptibility

Chemiotaxis in Infusoria, 19; in plasmodia of the Myxomycetes, 30; of duodenal mucous membrane, 64; of phagocytes, 79, 108, 133, 167, 177, 280; of leucocytes for rennet, &c., 119; positive, in segmentation-cells of frog embryo, 565

Cholera antibody (fixative), 253, 267, 292

Cholera, Asiatic, protective power of blood of convalescents from, 441; vaccinations against, 480–481

Cholera peritonitis, heredity of immunity against, 447, 448; immunity of guinea-pig against, 533

Cholera toxin, alligator resistant to, 333; immunisation against, 350; action of normal serum of goat on, 365

Cholera vibrio. See also Pfeiffer’s phenomenon, Vibrios

Cholera vibrio, adaptation of, to bactericidal substance, 23; susceptibility of larva of Rhinoceros beetle to, 40, 133; immunity of frog against, 142; of guinea-pig against, 163, 533; extracellular destruction of, 165, 212 (see also Pfeiffer’s phenomenon); eosinophile transformation in, 198; arthrospores of, 254; agglutination of, 261, 264; protective action of serums against, 268, 271, 318; 580of human blood against, 271, 318; immunity to, is not insusceptibility to its toxin, 290; origin of protective property against, 291; protective action of various fluids against, 320; antagonism between certain bacteria and, 324; in stomach, 419, 567; susceptible to acids in vitro, 419; in intestine, 423, 567; serum from animals immunised against, 532

Cholesterin. See also Fats

Cholesterin, fixation of toxins by, 387; fixation of saponin by, 389

Chytridium, 12

Cicatrisation of plants, 34

Clasmatocytes, 78

Clavelée (la). See Sheep-pox

Clavelisation against Sheep-pox, 460

Clothes-moths, micro-organisms absent from digestive canal of larvae of certain, 420

Coccobacillus prodigiosus. See under Micrococcus

Cockchafer larva, 70, 326

Complement of Ehrlich, 88, 91, 193, 251, 297

Complementoids of Ehrlich, 115

Concussion, spinal, adaptation to, 564

Conjunctiva, elimination of micro-organisms by the, 408; absorption of toxins by the, 409

Copula of P. Müller, 91

Cornea, protective resistance by the, 409

Crayfish, susceptible to certain toxins, 345; blood of, antitoxic against scorpion venom, 366; poor intestinal flora of, 421

Crickets and micro-organisms, 41, 133; natural immunity against toxins in, 329

Crustacea. See Crayfish, Daphnia

Crustacea, protective function of integument of, 404

Cyprinus. See Goldfish

Cytase of Laurent, 86

Cytases (syn. alexins, complements), 93, 98, 123; elaborated by phagocytes, 197, 252, 539, 549–556; thrown out into plasmas during phagolysis, 95, 99, 102, 197, 252, 551–554; bactericidal power of, 183, 184, 191, 193–198, 217 (see also Bactericidal, Body fluids, Serums); unity or plurality of, in same serum, 193, 197; absorption of, 194, 200; two kinds of, macrocytase and microcytase, 195, 296, 549; characters of the, 197, 549; enzymes other than, in phagocytes, 197; in the immunised organism, 250–255, 296, 317, 554; presence or absence of, how determined, 253; Ehrlich’s and author’s views on, contrasted, 297; compared with fixatives, 555

Cytotoxins, 105 (note), 110, 116

Daphnia, resistance of, to Blastomycetes, 131, 404, 520

Darwin on the extinction of the elephant, 8

Dermis, arrest of micro-organisms in the, 406

Desmon (of London), 91

Diastases. See Digestive ferments, Ferments

Digestion in the higher animals, 49, 59–65; psychical and nervous elements in, 62, 566; extracellular, by secreted juices, 49, 58, 62; the liver of the Mollusca as second organ of, 59; in the tissues, 67; and resorption closely related, 69, 85; by macrophagic organs, 85, 150

Digestion, intracellular. See also Phagocytes, Phagocytosis, Resorption

Digestion, intracellular, 48, 85, 517, 518, 520; in the Protozoa, 13, 30, 49; in Planarians, 49, 71, 82; in Actinians, 53, 82, 85; in Sponges, 69, 517; transition from, to digestion by secreted juices, 49, 58

Digestive ferments, antitoxic function of, 424; action of, on toxin of botulism, 420

Diphtheria, 7, 41, 132, 204; antitoxic power of blood of convalescents from, 443; antitoxic power against, in blood of healthy persons, 444; and in blood of new-born children, 445; heredity of immunity against, 445, 447, 448; influence of anticytase serum on, 371; vaccinations against, 495–503; serum against, 495; standardisation and testing of this serum, 496–498; its protective and antitoxic powers do not develop in equal ratio, 497; its prophylactic use, 498–503; accidents during treatment, 499, 502; statistics, 500–503

Diphtheria toxin, increased susceptibility of immunised guinea-pig to, 290; natural immunity of rat and mouse against, 204, 339; natural immunity of frog against, 330; immunisation against, 344, 347, 349, 353; attenuation of, 344; preventive action of nucleohiston on, 365; action of, on brain of laboratory animals, 386; sets up local lesions in the conjunctiva, 409; pepsin destroys, 419

Diplococcus pneumoniae. See Pneumococcus

Diseases, fear of, and pessimism, 1, 569; atrophic, probably due to a parasite, 3; mechanical element as etiological factor, 3; toxic element as etiological factor, 4; developed on the earth at a very early epoch, 8; and extinction of species, 8; infective, in multicellular plants, 29–39; set up by Fungi. See Fungi

Dog, immunity of, against anthrax, 149–151, 242; action of anthrax bacillus on rabid, 150; immunity of, against streptococci, 167; naturally refractory against a staphylococcus, 266; bactericidal action of blood of, on anthrax bacillus, 150, 151, 156; digestion of gelatine by leucocytes of, 108; enterokynase in lymphoid organs of, 61; digestive fluids of, 62–65; disinfecting power of small intestine of, 422; 581phagocytosis in, 149, 151; haematozoon in, 279

Domestic animals, immunisation of, against disease. See Bovidae, Dog, Goat, Horse, Pig, Sheep, Swine, Vaccines, Vaccinations

Dourine, 2, 247

Drepanidium, 515

Drugs, absorption of, by leucocytes, 400

Duodenum, chemiotaxis of mucous membrane of, 64

“Dust” cells, 75, 411–414

Eel’s serum. See also Ichthyotoxin

Eel’s serum, toxic action of, 20, 111, 563; and precipitins, 68, 106

Effusions of blood, fate of, 73

Ehrlich’s neutral red reaction, 13, 83, 181; classification of leucocytes, 74, 76–78; theory of side-chains or receptors, 120, 381–384, 538, 557, 562–563; compared with theory of phagocytes, 296–299, 538, 558; “immunising unit,” 373, 496

Elephant, extinction of, 8

Elimination of micro-organisms from the body, 43, 46; by the epidermis, 406; by the conjunctiva, 408; by the nasal mucosa, 410

Emys. See Turtle

Endo-enzymes, 197

Endotrypsin of yeast, 197

Enterokynase, 59, 98

Enzymes. See Ferments

Eosinophile leucocytes, secretion by, in bacteriolysis, 187, 542

Eosinophile staining reaction, 198

Epidermis, exfoliation of the, 406

Ernst’s bacillus, immunity of frog against, 140

Erysipelas. See Swine erysipelas

Erysipelas, immunity in, 434

Erysipelas streptococcus, protective action of, against anthrax, 323; its use in malignant tumours, 434

Excretion. See also Elimination

Excretion in relation to micro-organisms, 43, 432; of pepsin in the urine, 65; of pepsin in the blood, 66, 563

Exfoliation of the epidermis, 406

Exudations, bactericidal power of, 185, 193, 195

Farcy, slow evolution of, 406

Fats, protective action of, against toxins, 387

Ferments. See also Intestinal, Digestive, Fibrin-ferment, Gastric juice, Saliva, Trypsin

Ferments, Pasteur on the organised nature of, 2; soluble (diastases or enzymes), in digestion, 49, 55, 57, 108, 109, 197; antitoxic function of digestive, 424; phagocytic, 197, 549–559; hypersecretion of, 563

Fibrin ferment (plasmase), 95, 197, 550

Fishes. See Goldfish

Fishes, phagocytosis in, 135

Fixatives (immunising body, or amboceptor, or sensibilising substance), 88, 92–95, 97, 98, 103–105, 199–202, 296; synonyms of, 91; analogy of, with enterokynase, 98; presence of, in plasmas, 103, 112–114, 217; in protective serums, 269, 438; in mesenteric glands, 98; in spermotoxins, 101; origin of, 103, 294, 537, 556–559; specificity of, 88, 105, 216, 251, 253, 296; rarity of, in normal fluids, 199–201, 250; method of determining whether present in a serum, 199; absent from aqueous humour of immunised animals, 217, 222, 251; in the immunised organism, 250–255; properties of, 251, 253, 255, 554; differ from agglutinative substances, 255, 265, 559; relation of, to phagocytosis, 291, 295; part played by, in Pfeiffer’s phenomenon, 251, 295; and protective substances closely connected, 269, 294, 295, 561; compared with cytases, 555; mechanism of action of, 557

Food substances, absorption of, by other channel than alimentary canal, 67

Foods and antiseptics, 26

Foreign bodies, fate of, in organism, 46, 52, 55, 56, 517

Formed elements, resorption of the, 47, 67–105

Fowl, immunity of, against anthrax, 144, 159; phagocytosis in, 144, 282; bactericidal action of plasma of, on anthrax, 146; blood serum of, and tetanus, 204; immunity of, against tetanus, 204; natural immunity of, against tetanus toxin, 335; influence of removal of parts of brain and cord on tetanus in, 384

Fowl cholera, infection of laboratory animals with, 181; vaccine against, 208; phagocytosis in, 282; action of exudations of fowls vaccinated against, 288; acquired immunity against, 288, 508; failure of bacillus of, to grow in certain media, 510

Friedländer’s bacillus prevents infection by anthrax, 323

Frog, phagocytosis in, 137, 142; immunity of, against anthrax, 137; against Ernst’s bacillus, 140; against bacillus of mouse septicaemia, 141; against cholera vibrio, 142; acquired immunity of, against pyocyanic disease, 210, 301; natural immunity of, against tetanus toxin, 330; against diphtheria toxin, 330; immunisation of, against abrin, 345; absorption of tetanus toxin by brain of, 386

Frog embryo, positive chemiotaxis in segmentation-cells of, 565

Fungi, diseases set up by, 2, 4, 18, 32, 131, 135, 404 (see also Aspergillosis, Mycoses)

582Galactose. See Milk-sugar

Gamaleia’s vibrio. See Vibrio metchnikovi

Gastric juice, antiseptic action of, 417; psychic influence on, 63, 566. See Pepsin

Gelatine, resorption of, 107

Gentilly bacillus. See Pneumo-enteritis

Gerbil, tubercle in, 22, 183

Goat, action of normal serum of, on cholera toxin, 365; vaccination of, against rabies, 466; acquired immunity in, 563

Goldfish, 72, 135

Goose septicaemia. See Spirochaete anserina

“Greek method” of variolisation against small-pox, 507

Gruber’s theory of immunity, 256, 262

Guinea-pig, immunity of, against spirilla, 160, 162; against vibrios, 163, 211–227, 275, 287, 531, 533; against streptococci, 165; against tetanus bacillus, 169; against symptomatic anthrax, 171; against Trypanosomata, 173; acquired immunity against spirilla of recurrent fever, 227–230; against typhoid, 191, 230; against Bacillus pyocyaneus, 234–236; against anthrax, 276, 277; phagocytosis in, 162, 163, 166, 170, 223; hypersusceptibility of immunised, to diphtheria toxin, 290; protective power of serum of immunised, 293; effect of removal of spleen of, 293; antivenomous action of serum of, 338; immunisation of, against cholera toxin, 351; increasing natural susceptibility of, to toxins, 369, 370; reaction of, to atropin, 396

Haematopoietic organs. See also Lymphoid organs

Haematopoietic organs as source of protective substance, 292–294

Haematozoa. See Piroplasma, Trypanosoma

Haematozoon in dog closely allied to that of Texas fever, 279

Haemolysis. See also Blood corpuscles, resorption of

Haemolysis, 79–100, 111, 112, 537; the two substances which act in, 88, 98, 538; analogy between bacteriolysis and, 537

Haemomacrophages, 76, 136

Haptophore atomic group in a toxin, 120, 350, 384

Hedgehog, natural immunity of, against poisons and venoms, 337

Helix pomatia, 70, 134

Heredity of immunity, 445–453, 513

Herpestes. See Mongoose

Hibernation, effects on resistance to toxins, 339

Hippocampus, 135

Histogenic immunity, 336 (see Immunity, cellular)

Hog cholera, resemblance of bacillus of, to that of pneumo-enteritis, 259; serum of animals vaccinated against, 260; agglutination in, 260; protective action of serums against, 272; susceptibility of vaccinated animals to the toxin, 290

Horse. See also Diphtheria

Horse, acquired immunity against cholera vibrio, 222; against streptococci, 244, 245, 313; local reaction to tetanus toxin in, 352; immunised, with poor yield in antitoxin, 373, 375; reaction of, to one unit of toxin, 378; antitoxic power of serum of normal, 380; phagocytosis in, 245, 313; antivenomous action of serum of, 338; vaccination of, against rabies, 466; vaccination of, against anthrax, 470; protective serum against tetanus in, 493

Humoral phenomena in immunity, 184, 250, 290, 437–440, 525–531, 542, 543

Humoral theories of immunity, 184, 525–531, 542, 543; attempts to reconcile with theory of phagocytes, 539

Humours. See Body fluids, Serums

Hyperleucocytosis. See also Chemiotaxis

Hyperleucocytosis during immunisation, 352, 393

Hypersecretion, 563 (see Receptors)

Hypersusceptibility to toxins in immunised animals, 290, 368–374, 564

Hyphomycetes, diseases caused by, 2

Hypopyon, pus of, 96

Ichthyotoxin, 110, 120, 121, 122, 326, 360 (see also Eel’s serum)

Immunisation. See Immunity, acquired, artificial and temporary, Vaccination

Immunisation against toxins, principal methods of, 345–350; by unmodified toxins, 345–346; by modified toxins, 347; by mixtures of toxin and antitoxin, 348; by toxones and toxoids, 349; phenomena produced during, 352–354

Immunising body of Ehrlich, 91, 251; unit of Ehrlich, 373, 496

Immunity, historical sketch, 505–543; summary, 544–569; by attenuated micro-organisms, 2; predisposition or absence of, 7; against infective diseases, 9; definition of, 10; against micro-organisms, 10, 41, 42, 128–206, 207–324; against toxins, 10, 41, 42, 325–341, 342–402; not same as against micro-organisms, 290, 351; in unicellular organisms, 11–28; in multicellular plants, 29–39; in plants, action of manures on, 36; in the animal kingdom, 40–66; cellular or histogenic, 335, 336, 340, 563–565; active (Ehrlich), 378 = isopathic immunity (von Behring); passive (Ehrlich), 378, 453 = antitoxic immunity (von Behring); passive against micro-organisms, 300–324, 560; isopathic (von Behring), 378; 583antitoxic (von Behring), 378; of the skin, 403–407; of the mucous membranes, 407–432; susceptibility in, 565 (see also Hypersusceptibility, Susceptibility); channel of entrance in, 567; applications of theory of, to medical practice and to the research of new organisms, 567–569

Immunity, natural: 10, 17, 18, 30; amongst Invertebrates, 40, 131–135; amongst Vertebrata, 41, 135–174; against micro-organisms, 128–174, 175–206; and composition of body fluids, 128–131; against anaerobic bacteria, 169, 170; part played by inflammation in, 176; importance of microphages in, 177; humoral theory of, 184; agglutination in, 202, 206; against toxins, 325–341

Immunity, acquired: 10, 19, 31; against micro-organisms, 207–249, 250–299; against vibrios, 211–227; against pyocyanic disease, 210, 232–236, 301; against spirilla of recurrent fever, 227–230; against typhoid bacillus, 230; against swine erysipelas, 236–239; against anthrax, 239–242; against streptococcus, 243–247; against Trypanosomata, 247–249, 316; against staphylococcus, 266

Immunity, rapid and temporary: against micro-organisms, 300–324; conferred by specific serums, 301–317; conferred by normal serums, 317–320; conferred by fluids other than serums, 320–322; conferred by non-specific micro-organisms, 322–324

Immunity, artificial, against toxins, 342–402; against bacterial toxins, 343; against vegetable toxins, 344, 365; against snake venom, 345; not in direct ratio to amount of antitoxin in body fluids, 367–376

Immunity acquired by natural means, 433–453; acquired after recovery from infective diseases, 433–444; acquired by heredity, 445–453; conferred by maternal blood, 447; by the yolk, 449; by the milk of the mother, 449

Immunity, acquired: amongst Invertebrata, 209–210; amongst Vertebrata, 210–249; relation of Pfeiffer’s phenomenon to, 224; Bouchard’s theory of, 232, 286; double action of cytases and fixatives in, 250–255, 296, 554; agglutinative substances in, 242, 245, 256–265, 295, 542, 559; protective properties of body fluids in, 266–280; phagocytosis in, 220, 223–226, 245, 280–286, 295; origin of fixative properties in body fluids in, 294; relation between fixatives and phagocytosis in, 291, 295; humoral phenomena in, 184, 250, 290, 525–531, 542, 543; bactericidal power of fluids in, 250; Gruber’s theory of, 256, 262; against micro-organisms, susceptibility to the specific toxin in, 289; principal phenomena associated with, 295–296; against micro-organisms in no ratio to protective power of blood, 372–374; by suckling, mouse the only animal in which, 450, 452; theory of exhaustion of nutrient medium as cause of, 510–512; theory of presence of inhibitory substance, 511, 512; theory of local inflammatory reaction, 512; theory of adaptation of cells in, 513; theory of phagocytes in, 514–525, 539–543; theory of bactericidal power of body fluids, 525–531, 542, 543; theory of antitoxic power of body fluids, 531; theory of extracellular destruction of micro-organisms by leucocytic secretions, 187–191, 533–537, 542; theory of side-chains, 120, 381–384, 538, 557, 562–563; present phase of the question of, 540–543

Immunproteidin of Emmerich and Löw, 254

Infection, agents, mechanical and other, that prevent or aid, 3–5, 170–173, 426 (see also Diseases, Elimination, Micro-organisms)

Inflammation in immunity, 176, 512; Cohnheim on, 518; and phagocytosis, 516, 519–520, 547, 568

Influenza bacillus, cultivation of, in body fluids, 130, 554; vaccination against, 277

Infusoria. See also Trypanosoma

Infusoria, 12–20, 23, 26, 326

Inoculation. See Immunisation, Vaccination

Insects, natural immunity in, 132, 326, 329; acquired immunity in, 209; protective lining of digestive canal of, 421

Insusceptibility of cells of refractory animals, 341

Integument of Invertebrata, protective function of, 404

Intermediary body, 88, 91, 296, 557

Intestine, protective function of the, 422; microbian flora of, 420; antitoxic action of this flora, 427

Intestinal ferments, absence of microbicidal power from, 424, 567; intestinal micro-organisms, favouring and retarding functions of, 426; destruction of toxins by, 427

Invertebrata, natural immunity in the, 40, 131–135, 326–329; acquired immunity in the, 209–210, 301; immunisation of, by specific serums, 301; protective function of integument of, 404

Iodine trichloride in immunisation, 347

Iron, absorption of, by leucocytes, 399

Irritability, part played by, 18, 27 (see also Susceptibility); in plants, 38

Isaria, resistance to infection by, 329

Koch’s phenomenon in tuberculosis, 437

Kupffer’s cells, 75

584Leprosy, etiological factors in, 4

Leprosy bacillus, 75, 411

Leucocidin, and its neutralisation, 359

Leucocytes. See also Phagocytes

Leucocytes (amoeboid cells) in resorption, 47, 73, 175, 514, 515; adaptation of, to virulent bacteria, an education, 281; various categories of, 74–79; soluble ferments of, 95; chemiotaxis of, 119, 177; theory of bactericidal secretions by, 187–191, 533–537, 539, 540, 542; action of leucocidin on, 359; absorption of poisons by, 393–400; situations where there are no pre-existing, 551

Lily of the valley, acquired immunity in, 513, 515

Liver, serum against cytotoxin acting on, 116; protective function of the, 427; of Mollusca an organ of second digestion, 59

Lizard, resistance of, to tetanus toxin, 332

Lugol’s solution in immunisation, 347

Lupus, slow growth of, 406

Lymphocytes. See also Leucocytes, Phagocytes

Lymphocytes, 76, 78

Lymphoid organs. See also Haematopoietic organs, Phagocytic organs

Lymphoid organs, protective function of the, 428; as source of sensibilising substance (fixative), 537

Lymphomacrophages, 76

Macrocytase (alexin, complement), 86, 98, 105, 112, 196, 549; analogy of, with actinodiastase, 86; escape of, during phagolysis, 95, 99, 102, 552; presence of, in spermotoxin, 101; origin of, 103; active for resorption of animal cells, 196, 197, 296; in extracellular solution of red corpuscles, 552

Macrophages, 76, 77, 79, 547; the part they play in resorption, 80–100, 176; staining reactions of, 77; in phagocytosis, 144, 148, 154, 157, 161, 162, 164, 173, 184, 228, 245, 321, 548; act more especially in resorption of animal cells, 176, 196, 548; but intervene specially against human tubercle bacillus in pigeon, 148; against spirilla, 162, 177, 228; and against streptococci, 245; not source of bactericidal substance in body fluids, 187; part played by, in arsenic poisoning, 397; the principal source of antitoxin, 401; of skin, reaction of, against micro-organisms, 407

Macrophagic organs, digestive property of, 85, 150

Malaria, immunity against, 129, 278; protective action of serum in, 278; immunity acquired after, 434

Manures, influence on plant diseases, 36

Marmot, immunity of hibernating, against tetanus, 339

Martin’s broth (bouillon de panse), 473

Massowah vibrio, acquired immunity against, 221; action of specific serum on, 305

Mastzellen, 77

Membranes, protective secretion of, by bacteria, 21, 242

Meriones shawii, 22, 183

Mesenteric glands, 62, 85, 98, 195

Mesoderm, function of amoeboid cells of, 518

Microbicidal. See Bactericidal

Micrococcus prodigiosus, 42, 45; antagonistic to anthrax bacillus, 323; action of vaginal mucus on, 430

Microcytase digests bacteria, 196, 197, 296, 550; in immunity, 218; escape of, during phagolysis, 218, 222, 230, 295, 554; transforms vibrios into granules, 552; action of, on Vibrio metchnikovi, 553

Micro-organisms, minuteness of certain pathogenic, 3; variability in action of, 5; staining reactions of, 13, 83, 181, 183, 198, 213; immunity by attenuated, 2, 509; pathogenic, in healthy persons, 7; adaptation of, to toxic substances, 21, 25; protective secretion of membranes by, 21, 242; defence in plants against, 35; defences of animals against, 545; elimination of, from the body, 43, 46 (see also Elimination); resorption of, 46, 175, 546; antidiastase against enzymes of, 109; natural immunity against pathogenic, 128–174, 175–206; acquired immunity against pathogenic, 207–249, 250–299, 300–324; anaerobic, immunity against, 169, 170; pathogenic animal, 2, 173, 247–249, 277–279, 316; destruction of, an act of resorption, 175, 206 (see Bacteriolysis); presence of, in white corpuscles, 514; adaptation of phagocytes to destroy, 558, 566; mode of entry into phagocytes, 177; digested by phagocytes, 181, 514–525, 536, 539–543 (see Phagocytes, Phagocytosis); transformation into spherical granules, 198 (see also Pfeiffer’s phenomenon); extracellular destruction of, 165, 212, 533–537, 542; modified growth in serums from immunised animals, 256, 259 (see also Agglutination); specific diagnosis of, by modified growth, 256, 259; agglutination does not prevent growth of, 262; changes which they undergo in immunised animal, 289; attenuation of, 208, 286–289, 508; adjuvant and retarding functions of, 170, 426; antagonism between anthrax and certain, 323; antagonism between cholera vibrio and certain, 324; acidophile, 418; exfoliation of epidermis to get rid of, 406; localisation and arrest of, in the dermis, 406; 585destruction of toxins by, 427

Microphages, 77, 78, 79, 148, 152, 154, 162, 164, 172, 185, 245, 548; intervene specially against micro-organisms and in acute infections, 177, 196, 206, 549; source of bactericidal substance in body fluids, 187, 195; granular transformation of vibrios inside, 164, 165, 224 (see also Pfeiffer’s phenomenon)

Microsphaera, 18

Milk, absorption of, 107; precipitins in the differentiation of various kinds of, 107, 568; of immunised animals, antitoxin in, 356; immunity conferred by mother’s, 449, 450, 452; transmission of agglutinative power by, 450

Milk-sugar, adaptation of yeasts to, 26

Mithridates, method of protecting himself against poisons, 343

Mollusca. See also Helix, Phyllirhoë, Thetys

Mollusca, natural immunity in, 134; liver of, an organ of second digestion, 59

Mongoose, immunity of, against snake venom, 339

Monkeys, immunised, with poor yield in antitoxin, 373; immunisation of, against diphtheria toxin, 373; transient acquired immunity against recurrent fever, 434

Monospora, parasite of Daphnia disease, 131, 404, 520

Morphia, adaptation to, 343

Mouse, infection of, by swine erysipelas, 270, 307, 476; the only animal that acquires immunity by suckling, 450, 452; acquired immunity of, against typhoid, 230; natural immunity of, against diphtheria toxin, 204, 339

Mouse septicaemia, immunity of frog against, 141; phagocytosis in, 283; acquired immunity of rabbit against, 509

Mouth. See Buccal cavity

Mucous membranes, immunity of the, 407–432; elimination of micro-organisms by the nasal, 410; protective function of the genital, 429

Mycoses, pulmonary, 413 (see also Aspergillosis)

Mygale. See Spiders

Myriapods. See Scolopendra

Myxomycetes, plasmodia of, 30, 545

Naegeli’s theory of immunity, 512

Nagana disease, 2, 4, 247, 316 (see Trypanosoma)

Narcosis. See Opium

Nasal mucous membrane, elimination of organisms by, 410

Nepenthes, digestive juice of, 355

Nerve centres, susceptibility of, to toxins, 564

Neuroglia cells, their phagocytic function, 75

Neurotoxin, 116

Neutral red, reaction of, 13, 83, 181

Nuclein as a protective substance, 320; vaccinal against plague, 490

Nucleohiston, preventive action of, on diphtheria toxin, 365

Nutrition, certain diseases of, probably due to a parasite, 3; extra-buccal, 67, 69

Oidium albicans, growth of, in serum of immunised animals, 257

Omentum, glands of, 85; bactericidal power of extracts of, 195; phagocytosis of vibrios in, 224

Opium, its action on leucocytes, 225, 231, 236, 306, 307; its influence on immunisation by specific serums, 306; resistance of hedgehog to, 337

Oryctes nasicornis. See Rhinoceros beetle

Osmotic pressure, adaptation of plants to, 37, 39, 566; as cause of bactericidal action of body fluids, 193, 213

Ovum in the Graafian follicle, immunity acquired by the, 448

Oxalic acid, function of, in plants, 37, 566

Oxydases, 96

Pancreatic digestion, 60, 63, 65

Pancreatic juice, antitoxic power of, 424

Pancreatic secretion, its adaptation to kind of food, 64, 65

Paralysis, general progressive, and syphilis, 435

Paramaecia, 13, 16, 17, 19

Parasites in infective diseases, 2, 9 (see also Micro-organisms)

Pasteur’s theory of exhaustion of nutrient medium, 510–512; anthrax vaccines, 208, 470; modification of Willems’ method against pleuropneumonia, 477; vaccines against rabies, 462, 463–464; and Thuillier’s vaccines against swine erysipelas, 208, 473, 509

Pepsin in the urine, 65, 97; in the blood, 66, 563; antitoxic function of, 419; antiseptic action of, 417; chemical composition of, 109

Pessimism and fear of disease, 1, 569

Peyer’s patches, 61; protective function of, 428

Peziza. See Sclerotinia

Pfaundler’s reaction, 259

Pfeiffer’s phenomenon in cholera vibrio, 165, 192, 212–226, 251, 267, 268, 280, 301–307, 534–536; in spirillum of recurrent fever, 229; in typhoid bacillus, 230, 303, 304; in Bacillus pyocyaneus, 234, 307; different in immunised and in normal fluids, 251; conditions for its manifestation, 252, 253, 295, 534

Pfeiffer’s theory of immunity, 534

Phagocytes (See also Leucocytes), amoeboid cells with digestive function, 7, 182, 547; in Sponges, 69; in Vertebrata, 73; various categories of, 74–79; of Bipinnaria and Phyllirhoë, 70; 586chemiotaxis of, 79, 108, 133, 167, 177, 280; the source of the haemolytic ferment, 100; of osseous fishes, 135; of frog, 137; ingest living and virulent bacteria, 142, 177, 179–181, 558, 566; function of, 151, 157, 177, 181, 206, 547, 548, 566; mode of entry of microorganisms into, 177; acid reaction inside, 83, 182; action of opium on, 225, 231; theory of, and side-chain theory compared, 296–299, 538; in defence of animal against poisons, 393–400; in production of antitoxin, 400–402; in the defence of the skin, 407; attempts to reconcile theory of, with humoral theory, 539; history of theory of, 514–525, 539–543; stimulant action of, 532

Phagocytic crisis of Bordet, 314; ferments, 549–558; function of neuroglia cells, 75; organs, 85, 150, 292, 293, 537; of cricket, 133; of Ascaris, 547

Phagocytosis in osseous fishes, 135; in frogs, 137, 142; in fowl, 144, 282; in dog, 149, 151; in rat, 154, 157; in guinea-pig, 162, 163, 166, 170, 223; in horse, 245, 313; in rabbit, 159, 167, 169, 233, 239, 314; effect of removal of spleen on, 150; agents that prevent, 170–173 (see also Opium); neutralisation of toxins not necessary for, 205, 289; and agglutination, 202, 242, 245; ensures natural immunity, 206; action of opium on, 225, 231, 236, 306, 307; action of rabbit’s serum on, 231; in acquired immunity, 220, 223–226, 245, 280–286, 295, 313; relation to fixatives in acquired immunity, 291, 295; in the immunity conferred by specific serums, 303–317; history of, and of the theory of phagocytes, 514–525, 539–543; its application in surgery, 568

Phagolysis, 80, 99, 165; prevention of, 99, 218, 219, 220, 230, 252, 304; its relation to extracellular destruction of bacteria and Pfeiffer’s phenomenon, 218–220, 230, 280, 295, 534; escape of cytases during, 95, 99, 102, 191, 197, 252, 551–554, 560

Philocytase, 91, 92

Phloridzin, its action on natural immunity, 150

Phyllirhoë, two modes of digestion in, 58; resorption by phagocytes of, 70

Pig. See also Swine

Pig, protection of, against tetanus, 493

Pigeon, immunity of, against anthrax, 146; immunity of, against human tuberculosis, 147; immunity of, against influenza bacillus, 130, 554; its blood best culture medium for influenza bacillus, 130, 554; susceptible to swine erysipelas, 476; protective power of serum of, immunised against anthrax, 276, 277, 288; vaccination of, against anthrax, 276, 277

Pilocarpin augments production of antitoxin, 380

Piroplasma bigeminum, 247, 279

Plague, bubonic, rapid immunisation by serum, 312; protective influence of broth against, 321; production of antitoxic serum by, 401; infection by, through the nasal cavity, 409, 411; vaccinations against, 486–492; serum treatment in, 490–492; immunity against, when acquired and duration, 488, 489; statistics on vaccinations against, 488; prophylactic treatment against, 491; Reports of German and English Commissions on, 489

Planarians, digestion in, 49, 71, 82

Plants, immunity in multicellular, 29–39; cicatrisation of, 34; and osmotic pressure, 37, 39, 566; ravages of Sclerotinia amongst cultivated, 32; action of manures on immunity of cultivated, 36; function of oxalic acid in, 37, 566

Plasma, Gengou’s method of preparing, 157, 190

Plasmas. See also Body fluids, Serums

Plasmas, presence of fixatives in, 103; bactericidal power of, 190, 543

Plasmase (fibrin ferment), 95, 197, 550

Plasmodia, intracellular digestion in, 30, 545; chemiotaxis of, 30; adaptation of, to poisons, 30

Pleuropneumonia, bacterium of, 3, 130, 478, 569; vaccinations against, 477–479; action of serum from animals immunised against, 479; vaccinal methods used by savage races against, 506

Pneumococcus, modified growth of, in serums from immunised animals, 256, 262; vaccination against, 262; attenuated by serums from vaccinated animals, 287; agglutination of, 287

Pneumo-enteritis of swine, cocco-bacillus of, 259; action of serum of vaccinated rabbits on bacillus of, 260, 266, 287, 532; acquired immunity against, 260, 275, 311, 532

Pneumonia, fibrinous, relapses separated by periods of immunity, 434

Poisons. See also Toxins

Poisons, absorption of, by leucocytes, 393–400

Polyphagus euglenae, 12

Potato attacked by Bacillus coli, 35

Precipitins in the blood serum, 68, 106, 107; use of, in medico-legal investigations, 107, 568; and in the differentiation of various kinds of milk, 107, 568

Predisposition or absence of immunity, 7

Preventive substances of Bordet (syn. fixatives), 266

Profetta, law of, 453

Protective or anti-infective property. See also Antitoxic, Antitoxins, Blood, Body fluids, Serums

587Protective property, origin of, in serums and other fluids, 291–294; differs from agglutinative, 268, 269, 294; of blood and other fluids in convalescents, 437–444

Protective action of normal serums, 317–320; of fats against toxins, 387; of leucocytes against poisons, 393–400; of flow of a fluid, 431

Protective function of the skin, 404–407; in the respiratory channels, 411–414; of the cornea, 409; of the saliva, 415; of the intestine, 422; of the bile, 424; of the liver, 427; of the lymphoid organs, 428; of the suprarenal capsules, 431; in the urinary organs, 431

Protective substance resistant to heat, 268; and so distinguished from bactericidal substance, 268; closely connected with fixative substance, 269, 294, 295, 561

Protective vaccinations, 454–504

Proteus vulgaris, susceptibility of leucocytes to, 166, 179, 201, 282; eosinophile transformation in, 198; modified growth in certain serums, 259

Protozoa, intracellular digestion in the, 13, 30, 49; adaptation of, to saline solutions, 23, 515; and to physical conditions, 26

Prussic acid, antidote to, 363

Pseudo-diphtheria bacilli, 444

Pseudo-eosinophile leucocytes, secretion by, 187, 542

Pseudo-immunity or resistance, 320

Pus, ferment in, 96

Pyrogallic acid, its action on natural immunity, 150

Rabbit, immunity of, against anthrax bacillus, 159; against streptococci, 167, 168; against tetanus bacillus, 169; against cholera vibrio, 424; against pleuropneumonia, 569; acquired immunity of, against pyocyanic disease, 232; against swine erysipelas, 236–239, 527; against anthrax, 239, 323; against streptococcus, 243–247, 284–286, 312, 314; against pneumo-enteritis, 260, 266, 275, 311, 532; against pneumococcus, 262; against a staphylococcus, 266; against hog cholera, 290; against mouse septicaemia, 509; phagocytosis in, 159, 167, 169, 233, 239, 314, 569; infection by streptococci in, 283; action of serum of vaccinated, on bacillus of pneumo-enteritis, 287; action of agglutinated pneumococci on, 287; vaccinated against hog cholera susceptible to its toxin, 290; immunised against anthrax by means of the erysipelas coccus, 323; immunised against anthrax by products of Bacillus pyocyaneus, 323; infection by anthrax prevented by Friedländer’s bacillus, 323; brain of, very susceptible to action of tetanus toxin, 383; reaction of, to atropin, 395

Rabies, action of anthrax bacillus on, 150; action of normal ox serum on, 365; action of bile on, 425; heredity of immunity against, 446; vaccinations against, 461–466; statistics of vaccinations against, 464–466; in domestic animals, vaccinations against, 466

Rat, immunity of, against anthrax bacillus, 152, 526; against diphtheria bacillus, 204; acquired immunity against Trypanosomata, 247–249, 316; against anthrax, 240; natural immunity of, against diphtheria toxin, 204, 339; bactericidal ferment of phagocytes of, 20, 157; phagocytosis in, 154, 157

Receptors, 93, 120, 296; over-production of, 121, 296, 562; antitoxic and philotoxic functions of, 120; theory of, see Side-chain theory

Recurrent fever. See Spirilla, Spirochaete obermeyeri

Recurrent fever, transient acquired immunity against, 434

Rennet, 109, 119

Reptilia. See Alligator, Turtle, Snake, Lizard

Reptilia, natural immunity of, against tetanus toxin, 331–334

Resistance to disease, 8–10. See Immunity, Pseudo-immunity

Resorption of micro-organisms, 46, 175 (see also Immunity, cellular, Micro-organisms); of the formed elements, 47, 67–105; a true intracellular digestion, 85, 296; of cells in the Invertebrata, 70; of red corpuscles by phagocytes of the Vertebrata, 72, 80 (see also Phagocytes, Phagocytosis); part played by macrophages in (see Macrophages); and digestion closely related, 69, 85; of spermatozoa, 84, 100; of white corpuscles, 84 (see also Leucocytes, Phagocytes); of albuminoid substances, 106–127; of cells and the phenomena in acquired immunity, 296

Respiratory channels, protection by the, 411–414; absorption of poisons by the, 414

Rhinoceros beetle, natural immunity in larvae of, 132, 209, 326, 329; susceptibility to cholera vibrio, 40, 133

Ricin, 344, 360, 446, 449

Rinderpest, action of bile on, 425, 466; vaccinations against, 466–468; Koch’s method of vaccination against, 466; Kolle and Turner’s method of “simultaneous vaccinations” against, 467

Ring-worm, mechanical factor in, 4

Robin (toxalbumin of Robinia pseudacacia), 365; serum of animals vaccinated against, antitoxic, 365; heredity of immunity against, 446

Saccharomyces. See Yeasts

588Saline solution (physiological) as a protective fluid, 320, 365

Saliva, microbicidal property of the, 415; antitoxic function of, on snake venom, 417; psychic influence on flow of, 62, 566

Saponin, haemolytic action of, 389; and cholesterin, 389; and antisaponic power, 390

Saprolegnia. See Fungi

Sarcinae as adjuvant organisms, 426

Sarcinae, acidophile, 418

Sclerotinia, pathogenic action of, 32

Scolopendra, acquired immunity in, against anthrax, 209

Scorpion, natural immunity of, against tetanus toxin, 326; against its own poison, 327; antivenomous property of blood of, 328; supposed suicide of, 327

Scorpion serum, action of antivenomous serum on, 365

Scorpion venom, antitoxic action of crayfish blood against, 366

Scrofula in immunity against tuberculosis, 436

Secretion of bactericidal substance, theory of, 187–191, 533–537, 540, 542

Sensibilising substance of Bordet (fixative), 91, 199, 298, 535, 537, 557

Sensitiveness of plants to osmotic pressure, 37, 566

Septicaemia of goose. See Spirochaete anserina

Septicaemia of mouse. See Mouse septicaemia

Septic vibrio, 170

Serums. See also Blood, Body fluids, Humoral theory, Toxins

Serums, haemolysis by, 83, 87–95 (see also Haemolysis); effect of injections of, 68; increasing haemolytic power of, 90; isotoxic, 104; absorption of, 106; antihaemotoxic, 111, 112; haemolytic or haemotoxic, 111, 112; anticoagulating, 190; anticytase, 115, 371; antispermotoxic, 116, 122–126; bactericidal properties of, 184, 190, 191, 192, 193, 206, 211, 226, 233, 238, 241, 243, 244, 260, 298, 554; influence of alkalinity or acidity on bactericidal action of, 196; agglutination of red blood corpuscles by, 258; agglutination of bacteria by, 256–265, 380; protective power of, in the immunised organism, 266–280, 287, 293, 295, 532; differs from bactericidal power, 268; and from agglutinative power, 268; and is not a measure of acquired immunity, 271, 274, 275; protective, may be only feebly antitoxic, 497; modified growth of bacteria in immunised, 256, 259 (see also Agglutination); resistance to heat of protective substance of, 268; fixatives in protective, 269, 438; their origin, 294; protective and fixative substances contrasted, 269; relations of fixative and cytase in bactericidal action of, 298; stimulating action of, 270–274, 301, 308–320, 365; absence of protective power in specific, 270, 276–279; origin of protective power in, 291–294; theory of attenuation of micro-organisms by immune, 286–289; inactive specific, rendered active by addition of normal serum, 215, 268, 298, 302, 317; protective action of heated normal serum, 273, 318; protective action of non-specific, against toxins, 365; from convalescents, protective action of, 437–444; temporary immunity against micro-organisms conferred by specific, 301–317; conferred by normal, 317–320; conferred by fluids other than, 320–322; phagocytosis in the immunity conferred by specific, 303–306; influence of opium on immunisation by specific, 306; antivenomous action of, 334, 338, 358, 360, 361; antitoxic action of non-specific and normal, 365, 380; anti-arsenic, 390; antileucocidic, 359; antidiastatic, 361; testing and standardisation of antitoxic, 376, 476, 496–498

Sheath, protective. See Membrane

Sheep, natural immunity of, against anthrax, 159, 289; acquired immunity of, against anthrax, 241–3, 289; bactericidal action of blood serum of, 241, 286; protective power of serum of, immunised against anthrax, 276; immunised with blood from dog affected by a haematozoon, 279; vaccination of, against sheep-pox, 460; against rabies, 466; against anthrax, 469; protection against tetanus in, 493; fate of anthrax bacilli in Algerian, 512

Sheep-pox (la clavelée), heredity of immunity against, 452; vaccinations against, 460–461

Side-chains or receptors, theory of, 120, 381–384, 538, 557, 562–563; compared with theory of phagocytes, 296–299, 538, 558

Silver, soluble salts of, absorbed by leucocytes, 400

Skin, immunity of the, 403–407; protective function of the, 404–407; phagocytes in the defence of the, 407

Small-pox, mortality from, in 18th century, 454; vaccinations against, 454–460; vaccination with calf lymph, 456; with contents of pustule of cow-pox, 455; vaccination statistics, 457–459

Snail. See Helix pomatia

Snake, natural immunity of, against snake venom, 333

Snake venom, natural immunity of snakes against, 333; of hedgehog against, 337; of mongoose against, 339; artificial immunity against, 345, 347; action of antivenomous serum on, 358, 360, 361; of other specific serums on, 365; 589of cerebral substance on, 386; protective substances against, 387; action of saliva on, 417; action of bile on, 425; vaccination methods of savage races against, 506

Spermatozoa, resorption of, 84, 100; action of spermotoxin on, 101, 116, 125

Spermotoxin, 101, 116, 125

Spiders, natural immunity of, against tetanus toxin, 326

Spirilla, natural immunity against, 159; acquired immunity against, 227–230, 434; living in stomach of dog, 177; acidophile, 418

Spirochaete anserina, 160

Spirochaete obermeyeri, 160; acquired immunity against, 227–230; Pfeiffer’s phenomenon in, 229

Spleen, function of, 62, 85; action of extract of, on tetanus toxin, 365; effect of removal of, 150, 293; as source of fixative substance, 295, 537

Spleen and other haematopoietic organs as source of protective substance, 292–294; as source of agglutinins, 264; are phagocytic organs, 85, 150, 292

Sponges, digestion of, 69, 517

Staining reactions of cells and micro-organisms, 13, 77, 83, 181, 183, 198, 213

Standardisation of antidiphtheria serums, 376, 496–498; Ehrlich’s method, 496; Pasteur Institute method, 496–497

Staphylococcus, acquired immunity against, 266, 532; protective action of normal serum against, 319

Staphylococcus pyogenes in vagina, 430

Stellate cells of Kupffer, 75

Stimulant action. See also Body fluids, Protective

Stimulant action of serums, 270–274, 301, 308–320, 365; of phagocytes, 532; of normal fluids of the body, 559

Stimulins and their action in serums, 270–274

Stöhr’s phenomenon, 429

Stomach, acidophile microbian flora of, 418

Streptococci, protective sheath formed by, 22; immunity against, 165, 179, 282, 284–286; phagocytosis in immunity against, 245, 313; acquired immunity against, 243–247, 313; agglutination by serum of, 244, 245; reaction of animal organism against, 245–247; antitoxin against, 205; and phagocytosis, 283; action of specific serums on, 287, 288, 312; protective action of various fluids against, 320, 321

Streptococcic serum, action of, on leucocidin, 359

Sturin, bactericidal action of, 183

Suprarenal capsules, protective function of, 431

Susceptibility. See also Chemiotaxis, Hypersusceptibility, Irritability, Sensitiveness

Susceptibility of immunised animals to the specific toxin, 289; of frogs to tetanus toxin, 330; diminution of, in immunised animals, 374–376; in immunity, the part played by, 565; cellular, a general property of living beings, 565–566

Swine. See Pig, Pneumo-enteritis

Swine erysipelas, acquired immunity against, 236–239, 254, 283, 527; agglutination of bacilli of, 262; specific serum of, will not prevent infection, 270; phagocytosis in, 283; action of immune serums on bacillus of, 288, 289; protective action of specific serum against, 307; method of testing strength of serums against, 476; vaccinations against, 473–477; Pasteur’s method, 473; Lorenz’s method, 475; “serum-vaccinations” method, 475; vaccines against, 208, 473, 509

Swine plague, 259, 260

Synapta, 518

Syphilis, immunity in, 435; and general progressive paralysis, 435; law of Profetta in immunity against, 453; law of Baumès-Colles in, 436; transmission of, 452

Tears, microbicidal function of the, 408

Testing of serums. See Standardisation

Tetanolysin of Ehrlich, 349

Tetanospasmin, 362

Tetanus, immunisation against, 344, 347, 492–495; cerebral, in rabbit, 383, 391; difference between antitoxic action of living brain and that of cerebral emulsion on, 383; in fowl, 384; no antitetanic power in serum of convalescents, 443; vaccinations against, 492–495; vaccines against, 493; protective serum treatment against, 493–495

Tetanus antitoxin, hypothesis of nervous origin of, 381–385; nature of, 355; mode of action on toxin, 357, 381; of nerve centres locally restricted in its action, 382

Tetanus bacillus, natural immunity against, 169, 204

Tetanus toxin, natural immunity of spiders and scorpions against, 326; of larvae of Oryctes and of cricket against, 329; of frog against, 330; of reptiles against, 331–334; of fowl against, 335; of hibernating animals against, 339; attenuation of, 344; localisation of, in vascular organs, 336; brain of rabbit very susceptible to action of, 383; fixation of, by substance of nerve centres, 382; by certain parts of brain and cord, 386, 391; by other cells, 391, 392; action of emulsions of frog’s brain on, 386; fixation of, by carmine, 388, 394; absorption of, by leucocytes, 393–395; action of extract of spleen on, 365; 590toxone (tetanolysin) of, 349, 362; local reaction to, in horse, 352; heredity of immunity against, 446, 448, 450

Texas fever, acquired immunity of Bovidae against, 247, 279; attenuation of parasite of, in the tick, 247; haematozoon in dog closely allied to that of, 279

Thetys, 517

Thymus gland, immunising power of, 293

Tick, attenuation of parasite of Texas fever in, 247

Tonsils, protective function of, 428

Torulae as adjuvant organisms, 426

Toxins, immunity against, 10; immunity of unicellular organisms against, 19; adaptation of bacteria to, 21–27; of yeasts to, 20, 26; of plasmodia to, 30; action of, on Infusoria, 19, 326; composition of, 120; neutralisation of, not necessary for phagocytosis, 205, 289; immunity against micro-organism not same as against toxin, 251, 290; protective fixation of, by nerve elements and other cells, 386–400; methods of immunisation by modified and unmodified, 345–347 (see Immunisation); local reaction in immunisation against, 352; action of normal serums on, 365; of non-specific serums on, 365; protective action of fats against, 387; leucocytic reaction against, 393–400; absorption of, by the conjunctiva, 409; by the respiratory channels, 414; destruction of, by the intestinal organisms, 427; attenuation of, 344; natural immunity against, 325–341; artificial immunity against, 342–402; against bacterial, 343; against vegetable, 344, 365; heredity of immunity in phanerogamic, 446, 449; susceptibility of nerve centres to, 564

Toxoids, 349 (see also Toxophore); immunisation by, 350

Toxones, 349, 362; method of immunisation by, 349

Toxophore atomic group in toxin (= toxoid), 120, 350, 384

Trichinae, mechanical action of, 3

Tristeza (syn. Texas fever), 247

Tropidonotus. See Snake

Trypanosoma, 4, 129, 147; brucei, 9; lewisi, 173, 248

Trypanosomata, fate of, in refractory animal, 173; acquired immunity against, 247–249, 316; and agglutinative power, 278

Trypsin, antitoxic power of, 424

Tsetse fly, 4, 9, 129, 247

Tubercle bacillus, formation of sheath by, 22, 183

Tuberculin as a protective substance against cholera vibrio, 320

Tuberculosis, mechanical etiological factors in, 4

Tuberculosis, bacillus of, 22, 42, 143; avian, 41, 148, 149, 182; human, immunity of pigeon against, 147; acquired immunity in, 436; after scrofula, 436; Koch’s phenomenon in, 437

Tumours, malignant, probability of discovery of parasite of, 3; use of erysipelas streptococcus in, 434

Turtle, natural immunity of, against tetanus toxin, 332, 386

Typhoid, protective power of serum of convalescents from, 437–440; its agglutinative power, 439; serum-diagnosis of, 256, 257, 261, 439; immunity against, not acquired by suckling, 450; vaccinations against, 479, 481–486; Wright’s vaccine against, 482; bactericidal power of serum from persons immunised against, 483; statistics of vaccinations against, 483–485

Typhoid bacillus, 23, 143, 191, 198, 203; acquired immunity against, 230; attenuated Pfeiffer’s phenomenon in, 230, 303, 304; agglutination of, 260, 261, 380, 439; resistance to agglutinated, 263; protective action of serums against, 272–274, 293, 317, 319; origin of protective substance against, 292; of agglutinative property against, 294; protective action of various fluids against, 320; passes uninjured through stomach, 418; transmission by suckling, of agglutinative power against, 450

Typhoid infection, experimental, in laboratory animals, 230, 267; influence of anticytase serum on, 371; uncertainty of, by ingestion, 423

Typhoid septicaemia, experimental, heredity of immunity against, 447

Tyrosin, protective action of, 387

Unicellular organisms, immunity in, 11–28; infective diseases of, 12; irritability of, 27; adaptation of, to saline solutions, 23, 515

Unit, Ehrlich’s immunising, 373, 496

Urinary ferments, 66

Urinary organs, protective function in, 431

Urine as a protective fluid, 320, 431; pepsin in the, 65; amylase in the, 65

Vaccination. See also Immunisation

Vaccinations, protective, 208, 241, 267, 454–504, 507; with attenuated micro-organisms, 509

Vaccine against fowl cholera, 208

Vaccines against anthrax, 208, 470, 509; against swine erysipelas, 208, 473, 509; against rabies, 208, 462, 463–464; against symptomatic anthrax, 471; against small-pox, 455–457, 507; against pleuropneumonia, 477; against cholera, 481; against plague, 487, 489, 490; against tetanus, 493

591Vaccinia, supposed micro-organism of, 455–456

Vagina, autopurification of, 429

Variolisation, early use of, 455, 507

Venom. See Snake venom

Ver blanc, syn. cockchafer larva

Vibrio. See also Cholera vibrio, Massowah vibrio, Septic vibrio

Vibrios, acquired immunity against, 211–227; phagocytosis in immunity against, 220, 223–226; granular transformation of, 164, 165, 192, 212–226 (see Pfeiffer’s phenomenon); bacteriolysis (agglutination) of, 256; susceptibility of animals vaccinated against, to the toxins, 290

Vibrio metchnikovi, acquired immunity against, 211, 226, 527, 531; modified growth of, in serums from immunised animals, 156, 262; action of, grown in serum of vaccinated animals, 287; perishes in intestine of dog, 422; action of microcytase on, in hypervaccinated guinea-pigs, 553

Viper. See Snake, Snake venom

Viruses, attenuated, 208, 508; vaccination with, whose nature is as yet unknown. See Small-pox, Sheep-pox, Rabies, Rinderpest

Vitellus of egg of immunised fowl, tetanus antitoxin present in, 356; immunity conferred by, 449

Warlomont’s calf lymph vaccine, 456

Weber-Fechner, law of, 27, 38, 566

Willem’s method of vaccination against pleuropneumonia, 477; Pasteur’s modification of, 477

Wright’s method of vaccination against typhoid, 482; method of testing bactericidal power of body fluids, 483

Yeast-cells, adaptation of, to poisons, 20, 26; to milk-sugar, 26; destruction of injected, by phagocytes, 172; Curtis’s pathogenic, 172; endotrypsin of, 197; autodigestion in, 197; soluble ferments of, 253

Yeasts, diseases due to, 2

Yolk. See Vitellus

Zymase, 197, 550

CAMBRIDGE: PRINTED BY JOHN CLAY, M.A. AT THE UNIVERSITY PRESS.

TRANSCRIBER’S NOTES

Page Changed from Changed to

226 justified in thinking that the vibrionicidal property of the blood justified in thinking that the vibriocidal property of the blood

Typos fixed; non-standard spelling and dialect retained.

Used numbers for footnotes, placing them all at the end of the last chapter.

Explore with AITake your curiosity a little further.

Reading settings